Search Results - "Kroger, N."

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group by Kröger, N M, Deeg, J H, Olavarria, E, Niederwieser, D, Bacigalupo, A, Barbui, T, Rambaldi, A, Mesa, R, Tefferi, A, Griesshammer, M, Gupta, V, Harrison, C, Alchalby, H, Vannucchi, A M, Cervantes, F, Robin, M, Ditschkowski, M, Fauble, V, McLornan, D, Ballen, K, Popat, U R, Passamonti, F, Rondelli, D, Barosi, G

“…The aim of this work is to produce recommendations on the management of allogeneic stem cell transplantation (allo-SCT) in primary myelofibrosis (PMF). A…”
Get full text

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia by Craddock, Charles, Labopin, Myriam, Robin, Marie, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim, Bourhis, Jean Henri, Sengelov, Henrik, Blaise, Didier, Luft, Thomas, Hallek, Michael, Kröger, Nicolaus, Nagler, Arnon, Mohty, Mohamad

“…Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic…”
Get full text

Polycationic Peptides from Diatom Biosilica That Direct Silica Nanosphere Formation by Kröger, Nils, Deutzmann, Rainer, Sumper, Manfred

“…Diatom cell walls are regarded as a paradigm for controlled production of nanostructured silica, but the mechanisms allowing biosilicification to proceed at…”
Get full text

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment by Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R

“…Tyrosine kinase inhibitors represent today’s treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT)…”
Get full text

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma by Klyuchnikov, E, Bacher, U, Woo Ahn, K, Carreras, J, Kröger, N M, Hari, P N, Ku, G H, Ayala, E, Chen, A I, Chen, Y-B, Cohen, J B, Freytes, C O, Gale, R P, Kamble, R T, Kharfan-Dabaja, M A, Lazarus, H M, Martino, R, Mussetti, A, Savani, B N, Schouten, H C, Usmani, S Z, Wiernik, P H, Wirk, B, Smith, S M, Sureda, A, Hamadani, M

“…Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL…”
Get full text

Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research by Schoettler, M.L., Carreras, E., Cho, B., Dandoy, C.E., Ho, V.T., Jodele, S., Moissev, I., Sanchez-Ortega, I., Srivastava, A., Atsuta, Y., Carpenter, P., Koreth, J., Kroger, N., Ljungman, P., Page, K., Popat, U., Shaw, BE, Sureda, A., Soiffer, R., Vasu, S.

“…Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic cell transplantation (HCT)…”
Get full text

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT by Potter, V., Gras, L., Koster, L., Kroger, N., Sockel, K., Ganser, A., Finke, J., Labussiere-Wallet, H., Peffault de Latour, R., Koc, Y., Salmenniemi, U., Smidstrup Friis, L., Jindra, P., Schroeder, T., Tischer, J., Arat, M., Pascual Cascon, M., de Wreede, L. C., Hayden, P., Raj, K., Drozd-Sokolowska, J., Scheid, C., McLornan, D. P., Robin, M., Yakoub-Agha, I.

“…The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to…”
Get full text

Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation by Kroger, N

“…Allogeneic stem cell transplantation in multiple myeloma after standard myeloablative conditioning induces a high rate of complete remissions, but long-term…”
Get full text

Species-Specific Polyamines from Diatoms Control Silica Morphology by Kröger, N, Deutzmann, R, Bergsdorf, C, Sumper, M

“…Biomineralizing organisms use organic molecules to generate species-specific mineral patterns. Here, we describe the chemical structure of long-chain…”
Get full text

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT by Robin, M, Porcher, R, Zinke-Cerwenka, W, van Biezen, A, Volin, L, Mufti, G, Craddock, C, Finke, J, Richard, C, Passweg, J, Peniket, A, Maertens, J, Sucak, G, Gedde-Dahl, T, Vitek, A, Nagler, A, Blaise, D, Beelen, D, Maillard, N, Schwerdtfeger, R, de Witte, T, Kroger, N

“…We report a retrospective analysis of 246 myelodysplastic syndrome (MDS) patients in the EBMT (The European Society for Blood and Marrow Transplantation)…”
Get full text

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT by Savani, Bipin N, Labopin, Myriam, Kröger, Nicolaus, Finke, Jürgen, Ehninger, Gerhard, Niederwieser, Dietger, Schwerdtfeger, Rainer, Bunjes, Donald, Glass, Bertram, Socié, Gerard, Ljungman, Per, Craddock, Charles, Baron, Frédéric, Ciceri, Fabio, Gorin, Norbert Claude, Esteve, Jordi, Schmid, Christoph, Giebel, Sebastian, Mohty, Mohamad, Nagler, Arnon

“…The outcome of patients undergoing HLA-matched unrelated donor allogeneic hematopoietic cell transplantation following reduced-intensity conditioning or…”
Get full text

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation by Koenecke, Christian, Göhring, Gudrun, de Wreede, Liesbeth C, van Biezen, Anja, Scheid, Christof, Volin, Liisa, Maertens, Johan, Finke, Jürgen, Schaap, Nicolaas, Robin, Marie, Passweg, Jakob, Cornelissen, Jan, Beelen, Dietrich, Heuser, Michael, de Witte, Theo, Kröger, Nicolaus

“…The aim of this study was to determine the impact of the revised 5-group International Prognostic Scoring System cytogenetic classification on outcome after…”
Get full text

Viscoelasticity within the framework of isothermal two-mechanism models by Kröger, N.H., Böhm, M., Wolff, M.

“…► We present an extension of the classical description for linear viscoelasticity within the framework of two-mechanism models. ► The presented…”
Get full text

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report by Passweg, J R, Baldomero, H, Bader, P, Bonini, C, Duarte, R F, Dufour, C, Gennery, A, Kröger, N, Kuball, J, Lanza, F, Montoto, S, Nagler, A, Snowden, J A, Styczynski, J, Mohty, M

“…Hematopoietic stem cell transplantation (HSCT) is an established procedure for many acquired and congenital disorders of the hematopoietic system. A record…”
Get full text

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT by Robin, M, Porcher, R, Zinke-Cerwenka, W, van Biezen, A, Volin, L, Mufti, G, Craddock, C, Finke, J, Richard, C, Passweg, J, Peniket, A, Maertens, J, Sucak, G, Gedde-Dahl, T, Vitek, A, Nagler, A, Blaise, D, Beelen, D, Maillard, N, Schwerdtfeger, R, de Witte, T, Kroger, N

“…This corrects the article DOI: 10.1038/bmt.2016.266…”
Get full text

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually by Passweg, J R, Baldomero, H, Bader, P, Bonini, C, Cesaro, S, Dreger, P, Duarte, R F, Dufour, C, Kuball, J, Farge-Bancel, D, Gennery, A, Kröger, N, Lanza, F, Nagler, A, Sureda, A, Mohty, M

“…A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by…”
Get full text

Reply to 'Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome' by Kroger, N

Get full text

HAPLO IN MDS: MORE THAN DONOR AVAILABILITY by Kroger, N.

Get full text

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma by Atanackovic, D, Luetkens, T, Kröger, N

“…The adaptive immune system is clearly capable of recognizing and attacking malignant plasma cells in patients with multiple myeloma (MM). However, MM patients…”
Get full text

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation by Kröger, Nicolaus, Schilling, Georgia, Einsele, Hermann, Liebisch, Peter, Shimoni, Avichai, Nagler, Arnon, Perez-Simon, Jose A., San Miguel, Jesus F., Kiehl, Michael, Fauser, Axel, Schwerdtfeger, Rainer, Wandt, Hannes, Sayer, Herbert G., Myint, Han, Klingemann, Hans, Zabelina, Tatjana, Dierlamm, Judith, Hinke, Axel, Zander, Axel R.

“…We investigated in a retrospective multicenter study the impact of chromosome arm 13q deletion (13q-) as detected by fluorescence in situ hybridization (FISH)…”
Get full text